ICU Medical (ICUI) to Release Quarterly Earnings on Thursday

ICU Medical (NASDAQ:ICUI) will likely be announcing its Q1 2025 earnings results after the market closes on Thursday, May 8th. Analysts expect the company to announce earnings of $1.23 per share and revenue of $574.15 million for the quarter.

ICU Medical Trading Down 4.0 %

Shares of ICUI stock opened at $136.00 on Tuesday. The stock has a 50 day simple moving average of $141.24 and a 200-day simple moving average of $156.12. ICU Medical has a 1-year low of $96.97 and a 1-year high of $196.26. The company has a market cap of $3.35 billion, a price-to-earnings ratio of -29.76 and a beta of 0.86. The company has a debt-to-equity ratio of 0.75, a current ratio of 2.29 and a quick ratio of 1.03.

Wall Street Analysts Forecast Growth

A number of equities analysts have weighed in on the company. Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a research note on Tuesday, April 8th. KeyCorp lowered their price target on shares of ICU Medical from $209.00 to $191.00 and set an “overweight” rating on the stock in a research report on Monday, April 21st. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Friday. Finally, Raymond James set a $97.00 target price on shares of ICU Medical in a report on Wednesday, March 12th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, ICU Medical has an average rating of “Buy” and an average price target of $162.67.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.